title: Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging.
abstract: In vivo bioluminescent imaging permits the visualization of bacteria in live animals, allowing researchers to monitor, both temporally and spatially, the progression of infection in each animal. We sought to engineer stably luminescent clinical strains of Staphylococcus aureus, with the goal of using such strains in mouse models. The gram-positive shuttle vector pMAD was used as the backbone for an integration plasmid. A chloramphenicol resistance gene, a modified lux operon from Photorhabdus luminescens, and approximately 650 bp of homology to the chromosome of the USA300 S. aureus strain NRS384 were added, generating plasmid pRP1195. Electroporation into strain RN4220 followed by temperature shift led to integration of pRP1195 into the chromosome. The integrated plasmid was transferred to clinical strains by phage transduction. Luminescent strains displayed no in vitro growth defects. Moreover, luminescence was stable in vitro after three rounds of subculture over 48 hours of growth in the absence of antibiotics. Mice were infected with a luminescent strain of NRS384 in skin and intravenous models. In a mouse skin model, luminescent bacteria were present in lesions that formed and cleared over the course of several days, and in an intravenous model, bacteria inoculated in the mouse tail vein were observed spreading to multiple tissues. No statistically significant difference in virulence was observed between NRS384 and the luminescent strain in either infection model. These preliminary data suggest that this luminescent USA300 strain is suitable for use in mouse models. Similar strains were engineered using other sequenced clinical strains. Because these strains are stably luminescent, they should prove useful in animal models of infection.
authors.affiliation: Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. Roger.Plaut@fda.hhs.gov
authors.forename: Roger D
authors.initials: RD
authors.lastname: Plaut
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Mocca
authors.forename: Ranjani
authors.initials: R
authors.lastname: Prabhakara
authors.forename: Tod J
authors.initials: TJ
authors.lastname: Merkel
authors.forename: Scott
authors.initials: S
authors.lastname: Stibitz
mesh_terms: D000818:Animals; D001435:Bacteriophages / Q000235:genetics; D002876:Chromosomes, Bacterial / Q000235:genetics*; D018274:Electroporation; D018703:Founder Effect; D018014:Gene Transfer Techniques; D007275:Injections, Intravenous; D049449:Luminescence; D008163:Luminescent Measurements; D051379:Mice; D009876:Operon; D020637:Photorhabdus / Q000737:chemistry / Q000235:genetics; D010957:Plasmids; D013203:Staphylococcal Infections / Q000382:microbiology* / Q000401:mortality; D013211:Staphylococcus aureus / Q000235:genetics* / Q000302:isolation & purification / Q000648:ultrastructure; D016019:Survival Analysis
references.citation: Int J Med Microbiol. 2008 Oct;298(7-8):599-605
references.pmid: 18329335
references.citation: Nature. 1983 Oct 20-26;305(5936):709-12
references.pmid: 6226876
references.citation: Appl Environ Microbiol. 2004 Nov;70(11):6887-91
references.pmid: 15528558
references.citation: BMC Microbiol. 2007 Nov 06;7:99
references.pmid: 17986343
references.citation: Mol Microbiol. 2011 Feb;79(3):814-25
references.pmid: 21255120
references.citation: Infect Immun. 2000 Jun;68(6):3594-600
references.pmid: 10816517
references.citation: J Gen Microbiol. 1952 Feb;6(1-2):95-107
references.pmid: 14927856
references.citation: Lancet. 2010 May 1;375(9725):1557-68
references.pmid: 20206987
references.citation: Methods Mol Biol. 2008;416:103-16
references.pmid: 18392963
references.citation: Virology. 2010 Nov 25;407(2):381-90
references.pmid: 20869739
references.citation: Microbiol Rev. 1991 Mar;55(1):123-42
references.pmid: 2030669
references.citation: Lancet. 2002 May 25;359(9320):1819-27
references.pmid: 12044378
references.citation: Infect Immun. 2009 Jan;77(1):274-85
references.pmid: 18955476
references.citation: FEMS Microbiol Lett. 1997 Jun 1;151(1):1-8
references.pmid: 9198277
references.citation: J Bacteriol. 1982 May;150(2):815-25
references.pmid: 6950931
references.citation: Infect Immun. 2009 Jan;77(1):255-65
references.pmid: 18955474
references.citation: J Bacteriol. 2008 Jan;190(1):300-10
references.pmid: 17951380
references.citation: Infect Immun. 2003 Feb;71(2):882-90
references.pmid: 12540570
references.citation: Mol Biol Evol. 1983 Dec;1(1):57-66
references.pmid: 6100986
references.citation: J Orthop Res. 2012 Mar;30(3):335-40
references.pmid: 21837686